The odds of receiving first-line (FL) antibiotic therapy at pediatric urgent care centers (PUCs) were lower in White children ...

A population-wide cohort study in Ontario found that more than 15% of residents colonized with resistant bacteria went on to ...

SAN FRANCISCO, Dec. 3, 2024 /PRNewswire/ -- InsightRX – the leader in Bayesian model-informed precision dosing (MIPD) software – today announced it will attend the ASHP 2024 Midyear Clinical Meeting & ...

With the rapid development of antibiotics in the 1930s, phage therapy – using viruses known as bacteriophages or phages to ...

New research shows copper to be an effective weapon against spread of disease and bacteria in hospitals, particularly when ...

Antimicrobial resistance (AMR) is defined as resistance of microorganisms (bacteria, viruses, fungi or parasites) — to an antimicrobial agent against which they were thought to be previously sensitive ...

Fidaxomicin use in the treatment of CDI has significantly increased since the IDSA 2021 Clinical Guideline Update; however, its use is still low.

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ('we' or 'Acurx' or the 'Company'), a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, ...

Vancomycin is an antibiotic glycopeptide discovered in the 1950s and approved by Food and Drug Administration (FDA) to treat severe infections caused by gram-positive bacteria, especially ...

Research from Chalmers University of Technology, Sweden, shows that resistant bacteria can regain susceptibility to antibiotics when the treatment is combined with a material equipped with ...

Resistant bacteria regained susceptibility The peptide material was tested in bacterial cultures, in combination with two different antibiotics: oxacillin and vancomycin. The bacteria included in the ...